Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples
Keertan Dheda, Virginia Davids, Laura Lenders et al. · 2010
Read Clinical Utility of a Commercial LAM-ELISA Assay for TB Diagnosis in HIV-Infected Patients Using Urine and Sputum Samples by Keertan Dheda, Virginia Davids, Laura Lenders et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009848.txt.
Description
Tuberculosis is hard to confirm quickly in patients who also carry HIV. Keertan Dheda and colleagues tested a commercial urine and sputum test for that job. Their study appeared in PLOS ONE in 2010. Urine is far easier to collect than most samples.
The test is a LAM-ELISA assay, which hunts for a molecule shed by TB bacteria. Clinical utility means whether a test actually helps real diagnosis. The team judged the assay in HIV-infected patients, whose TB often hides. A fast, simple test would matter most where labs are scarce.
Catalog record
| CREATOR | Keertan Dheda, Virginia Davids, Laura Lenders et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009848